Brain Tumor Reports
54

Volume 17 Number 5
May 2015


Home > Publications > Brain Tumor Reports > Volume 17, Year 2015 > Number 5, May°


CONTENTS



BRAIN TUMORS
GLIOBLASTOMA
GLIOMAS
GLIOMATOSIS CEREBRI
HEMANGIOPERICYTOMA
MEDULLOBLASTOMA
MENINGIOMA
METASTATIC TUMORS
SUPRATENTORIAL PRIMITIVE NEUROECTODERMAL TUMOR





BRAIN TUMORS



Herold-Mende C, Mock A.
Microenvironment and brain tumor stem cell maintenance: impact of the niche.
Anticancer Agents Med Chem. 2014;14(8):1065-74. DOI: 10.2174/1871520614666140825103636
Source | Abstract | Full text | Similar articles





GLIOBLASTOMA



Alexandru-Abrams D, Jadus MR, Hsu FP, Stathopoulos A, Bota DA.
Therapeutic targeting of malignant glioma.
Anticancer Agents Med Chem. 2014;14(8):1075-84. DOI: 10.2174/1871520614666140825105145
Source | Abstract | Full text | Similar articles




Adeberg S, König L, Bostel T, Harrabi S, Welzel T, Debus J, Combs SE.
Glioblastoma Recurrence Patterns After Radiation Therapy With Regard to the Subventricular Zone.
Int J Radiat Oncol Biol Phys. 2014 Sep 11. pii: S0360-3016(14)03534-2. doi: 10.1016/j.ijrobp.2014.07.027. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Carruthers R, Ahmed SU, Strathdee K, Gomez-Roman N, Amoah-Buahin E, Watts C, Chalmers AJ.
Abrogation of radioresistance in glioblastoma stem-like cells by inhibition of ATM kinase.
Mol Oncol. 2014 Aug 24. pii: S1574-7891(14)00185-9. doi: 10.1016/j.molonc.2014.08.003. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Gallego O, Cuatrecasas M, Benavides M, Segura PP, Berrocal A, Erill N, Colomer A, Quintana MJ, Balaña C, Gil M, Gallardo A, Murata P, Barnadas A.
Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry.
J Neurooncol. 2014 Jan;116(2):413-9. doi: 10.1007/s11060-013-1316-y. Epub 2013 Dec 19.
Source | Abstract | Full text | Similar articles




Garrido W, Rocha JD, Jaramillo C, Fernandez K, Oyarzun C, San Martin R, Quezada C.
Chemoresistance in high-grade gliomas: relevance of adenosine signalling in stem-like cells of glioblastoma multiforme.
Curr Drug Targets. 2014;15(10):931-42 DOI: 10.2174/1389450115666140826122315
Source | Abstract | Full text | Similar articles




Hamm R, Zeino M, Frewert S, Efferth T.
Up-regulation of cholesterol associated genes as novel resistance mechanism in glioblastoma cells in response to archazolid B.
Toxicol Appl Pharmacol. 2014 Sep 11. pii: S0041-008X(14)00325-1. doi: 10.1016/j.taap.2014.08.033. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Kanner AA, Wong ET, Villano JL, Ram Z; on behalf of EF-11 Investigators.
Post Hoc Analysis of Intention-to-Treat Population in Phase 3 Comparison of NovoTTF-100A™ System Versus Best Physician's Choice Chemotherapy.
Semin Oncol. 2014 Sep 11. pii: S0093-7754(14)00201-2. doi: 10.1053/j.seminoncol.2014.09.008. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Kast RE, Karpel-Massler G, Halatsch ME.
CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.
Oncotarget. 2014 Sep 30;5(18):8052-82. Epub 2014 Aug 29.
Source | Abstract | Full text | Similar articles




Kim SS, Rait A, Kim E, Pirollo KF, Chang EH.
A tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme.
Nanomedicine. 2014 Sep 18. pii: S1549-9634(14)00528-0. doi: 10.1016/j.nano.2014.09.005. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Mrugala MM, Engelhard HH, Dinh Tran D, Kew Y, Cavaliere R, Villano JL, Annenelie Bota D, Rudnick J, Love Sumrall A, Zhu JJ, Butowski N.
Clinical Practice Experience with NovoTTF-100A™ System for Glioblastoma: the Patient Registry Dataset (PRiDe).
Semin Oncol. 2014 Sep 11. pii: S0093-7754(14)00203-6. doi: 10.1053/j.seminoncol.2014.09.010. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Thomas AA, Omuro A.
Current role of anti-angiogenic strategies for glioblastoma.
Curr Treat Options Oncol. 2014 Dec;15(4):551-66. doi: 10.1007/s11864-014-0308-2. Epub 2014 Aug 31.
Source | Abstract | Full text | Similar articles




SUBVENTRICULAR ZONE


Chen L, Guerrero-Cazares H, Ye X, Ford E, McNutt T, Kleinberg L, Lim M, Chaichana K, Quinones-Hinojosa A, Redmond K.
Increased subventricular zone radiation dose correlates with survival in glioblastoma patients after gross total resection.
Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):616-22. doi: 10.1016/j.ijrobp.2013.02.014. Epub 2013 Mar 26.
Source | Abstract | Full text | Similar articles




Gibbs IC, Haas-Kogan D, Terezakis S, Kavanagh BD.
The subventricular zone neural progenitor cell hypothesis in glioblastoma: epiphany, Trojan Horse, or Cheshire fact?
Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):606-8. doi: 10.1016/j.ijrobp.2013.03.002.
Source | Abstract | Full text | Similar articles




Goffart N, Kroonen J, Rogister B.
Glioblastoma-initiating cells: relationship with neural stem cells and the micro-environment.
Cancers (Basel). 2013 Aug 14;5(3):1049-71. doi: 10.3390/cancers5031049.
Source | Abstract | Full text | Similar articles




Jafri NF, Clarke JL, Weinberg V, Barani IJ, Cha S.
Relationship of glioblastoma multiforme to the subventricular zone is associated with survival.
Neuro Oncol. 2012 Oct 24. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Kroonen J, Nassen J, Boulanger YG, Provenzano F, Capraro V, Bours V, Martin D, Deprez M, Robe P, Rogister B.
Human glioblastoma-initiating cells invade specifically the subventricular zones and olfactory bulbs of mice after striatal injection.
Int J Cancer. 2011 Aug 1;129(3):574-85. doi: 10.1002/ijc.25709. Epub 2010 Nov 23.
Source | Abstract | Full text | Similar articles




Lee P, Eppinga W, Lagerwaard F, Cloughesy T, Slotman B, Nghiemphu PL, Wang PC, Kupelian P, Agazaryan N, Demarco J, Selch MT, Steinberg M, Kang JJ.
Evaluation of high ipsilateral subventricular zone radiation therapy dose in glioblastoma: a pooled analysis.
Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):609-15. doi: 10.1016/j.ijrobp.2013.01.009. Epub 2013 Feb 22.
Source | Abstract | Full text | Similar articles




ELECTRIC FIELDS


Miranda PC, Mekonnen A, Salvador R, Basser PJ.
Predicting the electric field distribution in the brain for the treatment of glioblastoma.
Phys Med Biol. 2014 Aug 7;59(15):4137-47. doi: 10.1088/0031-9155/59/15/4137. Epub 2014 Jul 8.
Source | Abstract | Full text | Similar articles




Pless M, Weinberg U.
Tumor treating fields: concept, evidence and future.
Expert Opin Investig Drugs. 2011 May 9;. http://dx.doi.org/10.1517/13543784.2011.583236 [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Ram Z, Gutin PH and Stupp R on behalf of the EF-11 study investigators.
Subgroup and quality of life analyses of the phase III clinical trial of NovoTTF-100A versus best standard chemotherapy for recurrent glioblastoma.
Abstracts from the 15th Annual Meeting of the Society for Neuro-Oncology (SNO), November 18–21, 2010, Montreal, Quebec, Canada
Neuro Oncol (2010) 12 (suppl 4): iv36-iv57. November 2010. Abstract no. NO-55. 
Source | Abstract | Full text | Similar articles




Stupp R, Wong ET, Kanner AA, Steinberg D, Engelhard H, Heidecke V, Kirson ED, Taillibert S, Liebermann F, Dbalý V, Ram Z, Lee Villano J, Rainov N, Weinberg U, Schiff D, Kunschner L, Raizer J, Honnorat J, Sloan A, Malkin M, Landolfi JC, Payer F, Mehdorn M, Weil RJ, Pannullo SC, Westphal M, Smrcka M, Chin L, Kostron H, Hofer S, Bruce J, Cosgrove R, Paleologous N, Palti Y, Gutin PH.
NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality.
Eur J Cancer. 2012 May 17. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Stupp R, Kanner A, Engelhard H, Heidecke V, Taillibert S, Lieberman FS, Dbalý V, Kirson ED, Palti Y, Gutin PH.
A prospective, randomized, open-label, phase III clinical trial of NovoTTF-100A versus best standard of care chemotherapy in patients with recurrent glioblastoma.
J Clin Oncol (Meeting Abstracts) 2010 28: LBA2007. June 20, 2010
Source | Abstract | Full text | Similar articles | News




Turner SG, Gergel T, Wu H, Lacroix M, Toms SA.
The effect of field strength on glioblastoma multiforme response in patients treated with the NovoTTF™-100A system.
World J Surg Oncol. 2014 May 22;12(1):162. doi: 10.1186/1477-7819-12-162.
Source | Abstract | Full text | Similar articles





GLIOMAS



Kirkpatrick JP, Sampson JH.
Recurrent malignant gliomas.
Semin Radiat Oncol. 2014 Oct;24(4):289-98. doi: 10.1016/j.semradonc.2014.06.006.
Source | Abstract | Full text | Similar articles




Qiao G, Li Q, Peng G, Ma J, Fan H, Li Y.
Similarity on neural stem cells and brain tumor stem cells in transgenic brain tumor mouse models.
Neural Regen Res. 2013 Sep 5;8(25):2360-9. doi: 10.3969/j.issn.1673-5374.2013.25.007.
Source | Abstract | Full text | Similar articles




Shi L, Fei X, Sun G, Wang Z, Wan Y, Zeng Y, Guo J.
Hypothermia Stimulates Glioma Stem Spheres to Spontaneously Dedifferentiate Adjacent Non-stem Glioma Cells.
Cell Mol Neurobiol. 2014 Sep 17. doi:10.1007/s10571-014-0114-1. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Vriend J, Reiter RJ.
Melatonin as a proteasome inhibitor. Is there any clinical evidence?
Life Sci. 2014 Oct 12;115(1-2):8-14. doi: 10.1016/j.lfs.2014.08.024. Epub 2014 Sep 16.
Source | Abstract | Full text | Similar articles




HIGH-GRADE GLIOMAS


Clavo B, Robaina F, Jorge IJ, Cabrera R, Ruiz-Egea E, Szolna A, Otermin E, Llontop P, Carames MA, Santana-Rodríguez N, Sminia P.
Spinal cord stimulation as adjuvant during chemotherapy and reirradiation treatment of recurrent high-grade gliomas.
Integr Cancer Ther. 2014 Nov;13(6):513-9. doi: 10.1177/1534735414550037. Epub 2014 Sep 15.
Source | Abstract | Full text | Similar articles




Koekkoek JA, Dirven L, Sizoo EM, Pasman HR, Heimans JJ, Postma TJ, Deliens L, Grant R, McNamara S, Stockhammer G, Medicus E, Taphoorn MJ, Reijneveld JC.
Symptoms and medication management in the end of life phase of high-grade glioma patients.
J Neurooncol. 2014 Aug 24. doi:10.1007/s11060-014-1591-2. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Li W, Ma L, Wang X, Sun J, Wang S, Hu X.
11C-choline PET/CT tumor recurrence detection and survival prediction in post-treatment patients with high-grade gliomas.
Tumour Biol. 2014 Sep 3. doi:10.1007/s13277-014-2549-x. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Hyperthermia


Sun J, Guo M, Pang H, Qi J, Zhang J, Ge Y.
Treatment of malignant glioma using hyperthermia.
Neural Regen Res. 2013 Oct 15;8(29):2775-82. doi: 10.3969/j.issn.1673-5374.2013.29.009
Source | Abstract | Full text | Similar articles




LOW-GRADE GLIOMAS


Ajlan A, Recht L.
Supratentorial low-grade diffuse astrocytoma: medical management.
Semin Oncol. 2014 Aug;41(4):446-57. doi: 10.1053/j.seminoncol.2014.06.013. Epub 2014 Jul 1.
Source | Abstract | Full text | Similar articles





GLIOMATOSIS CEREBRI



Bertero L, Cassoni P, Rudà R.
Nocardia abscesses mimicking tumor progression in gliomatosis cerebri responding to temozolomide.
J Neurooncol. 2014 Sep 5. doi:10.1007/s11060-014-1609-9. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





HEMANGIOPERICYTOMA



Li D, Zhang JT.
Misinterpretation of statistical results and recurrent intracranial hemangiopericytoma.
J Neurooncol. 2014 Jan;116(2):421-2. doi: 10.1007/s11060-013-1297-x. Epub 2013 Nov 2.
Source | Abstract | Full text | Similar articles




Tian R, Hao S, Hou Z, Bian L, Zhang Y, Wu W, Xu F, Li H, Liu B.
Clinical characteristics and prognostic analysis of recurrent hemangiopericytoma in the central nervous system: a review of 46 cases.
J Neurooncol. 2013 Oct;115(1):53-9. doi: 10.1007/s11060-013-1193-4. Epub 2013 Jul 4.
Source | Abstract | Full text | Similar articles





MEDULLOBLASTOMA



Jones B.
Patterns of failure after proton therapy in medulloblastoma.
Int J Radiat Oncol Biol Phys. 2014 Sep 1;90(1):25-6. doi: 10.1016/j.ijrobp.2014.05.054.
Source | Abstract | Full text | Similar articles




Sethi RV, Giantsoudi D, Raiford M, Malhi I, Niemierko A, Rapalino O, Caruso P, Yock TI, Tarbell NJ, Paganetti H, MacDonald SM.
Patterns of failure after proton therapy in medulloblastoma; linear energy transfer distributions and relative biological effectiveness associations for relapses.
Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):655-63. doi: 10.1016/j.ijrobp.2013.11.239.
Source | Abstract | Full text | Similar articles





MENINGIOMA



Kim MS, Kim KH, Lee EH, Lee YM, Lee SH, Kim HD, Kim YZ.
Results of immunohistochemical staining for cell cycle regulators predict the recurrence of atypical meningiomas.
J Neurosurg. 2014 Nov;121(5):1189-200. doi: 10.3171/2014.7.JNS132661. Epub 2014 Aug 22.
Source | Abstract | Full text | Similar articles




Mordechai O, Postovsky S, Vlodavsky E, Eran A, Constantini S, Dotan E, Cagnano E, Weyl-Ben-Arush M.
Metastatic Rhabdoid Meningioma with BRAF V600E Mutation and Good Response to Personalized Therapy: Case Report and Review of the Literature.
Pediatr Hematol Oncol. 2014 Aug 12. http://dx.doi.org/10.3109/08880018.2014.936058. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





METASTATIC TUMORS



Chaichana KL, Rao K, Gadkaree S, Dangelmajer S, Bettegowda C, Rigamonti D, Weingart J, Olivi A, Gallia GL, Brem H, Lim M, Quinones-Hinojosa A.
Factors associated with survival and recurrence for patients undergoing surgery of cerebellar metastases.
Neurol Res. 2014 Jan;36(1):13-25. doi: 10.1179/1743132813Y.0000000260. Epub 2013 Oct 23.
Source | Abstract | Full text | Similar articles




Patel KR, Prabhu RS, Kandula S, Oliver DE, Kim S, Hadjipanayis C, Olson JJ, Oyesiku N, Curran WJ, Khan MK, Shu HK, Crocker I.
Intracranial control and radiographic changes with adjuvant radiation therapy for resected brain metastases: whole brain radiotherapy versus stereotactic radiosurgery alone.
J Neurooncol. 2014 Sep 5. doi:10.1007/s11060-014-1601-4. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Yang TJ, Oh JH, Folkert MR, Gupta G, Shi W, Zhang Z, Morikawa A, Seidman A, Brennan C, Yamada Y, Chan TA, Beal K.
Outcomes and prognostic factors in women with 1 to 3 breast cancer brain metastases treated with definitive stereotactic radiosurgery.
Int J Radiat Oncol Biol Phys. 2014 Nov 1;90(3):518-25. doi: 10.1016/j.ijrobp.2014.06.063. Epub 2014 Sep 3.
Source | Abstract | Full text | Similar articles





SUPRATENTORIAL PRIMITIVE NEUROECTODERMAL TUMOR



Bode U, Zimmermann M, Moser O, Rutkowski S, Warmuth-Metz M, Pietsch T, Kortmann RD, Faldum A, Fleischhack G.
Treatment of recurrent primitive neuroectodermal tumors (PNET) in children and adolescents with high-dose chemotherapy (HDC) and stem cell support: results of the HITREZ 97 multicentre trial.
J Neurooncol. 2014 Sep 2. doi:10.1007/s11060-014-1598-8. [Epub ahead of print]
Source | Abstract | Full text | Similar articles